[3]While psychedelics are not new, medical research around psychedelics has exploded in recent years. Silicon Valley and Wall Street have begun investing money into psychedelics research and development. These will likely be significant hurdles to overcome, given the high risks involved in research with controlled substances. Despite the surge in the number of research institutes and universities interested in conducting psychedelics research, many transactional challenges continue to impede the negotiation of research and development agreements in the field. ConclusionRecent regulatory and scientific developments—along with the push from Senators Schatz and Booker—signal that FDA approval for psychedelics may be on the horizon.

Source: Wall Street Journal May 28, 2022 01:48 UTC